Src Kinases Mediate STAT Growth Pathways in Squamous Cell Carcinoma of the Head and Neck*

Signal transducer and activator of transcription (STAT) proteins are constitutively activated in many malignancies, including squamous cell carcinoma of the head and neck (SCCHN). Previously, we reported that phosphorylation of the epidermal growth factor receptor (EGFR) is linked to activation of STATs 3 and 5 in SCCHN cells. The present study was undertaken to determine the role of Src family kinases in STAT activation and SCCHN growth. The Src family kinases c-Src, c-Yes, Fyn, and Lyn were expressed and activated by transforming growth factor-α stimulation in all four SCCHN cell lines examined but not in corresponding normal epithelial cells. In nine SCCHN cell lines tested, Src phosphotyrosine expression levels were highly correlated with activation levels of STATs 3 and 5. Co-immunoprecipitation analysis demonstrated interaction between c-Src and STATs 3 or 5 and EGFR in SCCHN cells, but no heterodimerization was detected between STAT3 and STAT5. SCCHN cells treated with either of two Src-specific inhibitors or transfected with a dominant-negative c-Src construct demonstrated decreased activation of STATs 3 and 5 and reduced growth rates in vitro. These results demonstrate a role for Src kinases in mediating activation of STATs 3 and 5 in concert with the EGFR in SCCHN cells. Strategies to target Src activation may contribute to the treatment of cancers that demonstrate increased levels of EGFR and STATs, including SCCHN.

[1]  Roy Garcia,et al.  STATs in oncogenesis , 2000, Oncogene.

[2]  J. Turkson,et al.  Activation of Stat3 in v-Src-transformed Fibroblasts Requires Cooperation of Jak1 Kinase Activity* , 2000, The Journal of Biological Chemistry.

[3]  Matthew B. Wilson,et al.  Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr–Abl signal transduction and oncogenesis , 2002, Oncogene.

[4]  J. Darnell.  Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[5]  M. Miloso,et al.  Post-transcriptional Control Regulates Transforming Growth Factor α in the Human Carcinoma KB Cell Line* , 1996, The Journal of Biological Chemistry.

[6]  J. Darnell.  STATs and gene regulation. , 1997, Science.

[7]  I. Kerr,et al.  Jaks and Stats in signaling by the cytokine receptor superfamily. , 1995, Trends in genetics : TIG.

[8]  J. Rosen,et al.  Differential Effects of Prolactin andsrc/abl Kinases on the Nuclear Translocation of STAT5B and STAT5A* , 1999, The Journal of Biological Chemistry.

[9]  J. Grandis,et al.  Retinoic acid normalizes the increased gene transcription rate of TGF–α and EGFR in head and neck cancer cell lines , 1996, Nature Medicine.

[10]  S. Parsons,et al.  Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Smithgall,et al.  Activation of STAT3 by the Src Family Kinase Hck Requires a Functional SH3 Domain* , 2002, The Journal of Biological Chemistry.

[12]  N. Bazan,et al.  Phosphorylation of STAT-3 in Response to Basic Fibroblast Growth Factor Occurs through a Mechanism Involving Platelet-activating Factor, JAK-2, and Src in Human Umbilical Vein Endothelial Cells , 2002, The Journal of Biological Chemistry.

[13]  S. Akira,et al.  Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway , 1994, Cell.

[14]  J. Grandis,et al.  Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro. , 1998, The Journal of clinical investigation.

[15]  G. Michalopoulos,et al.  STAT 1α/1β, STAT 3 and STAT 5: Expression and Association with c-MET and EGF-Receptor in Long-Term Cultures of Human Hepatocytes , 1999 .

[16]  Matthew B. Wilson,et al.  The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells , 2002, The EMBO journal.

[17]  G. Gillespie,et al.  Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples. , 2002, Cancer research.

[18]  A. Levitzki,et al.  Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor , 1996, Nature.

[19]  J. Darnell,et al.  Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. , 1994, Science.

[20]  J. Grandis,et al.  STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[21]  Y. Tan,et al.  Activation and association of Stat3 with Src in v-Src-transformed cell lines , 1996, Molecular and cellular biology.

[22]  T. Yeatman,et al.  Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Iacocca,et al.  Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  S. Parsons,et al.  STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor* , 2003, The Journal of Biological Chemistry.

[25]  M. Willingham,et al.  EGF-R antisense RNA blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinoma cell line. , 1992, The Journal of biological chemistry.

[26]  J. Darnell,et al.  A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. , 1993, Science.

[27]  T. Yeatman,et al.  Role of Src expression and activation in human cancer , 2000, Oncogene.

[28]  D. Tweardy,et al.  Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells , 1997, Oncogene.

[29]  G. Stark,et al.  Regulation of STAT‐dependent pathways by growth factors and cytokines , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  J. Darnell,et al.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.

[31]  S. Pathak,et al.  Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. , 1988, Cancer research.

[32]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[33]  Simon C Watkins,et al.  Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. D. Showalter,et al.  Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors. , 2000, Biochemical pharmacology.

[35]  M. Wicha,et al.  Factors Affecting the Growth of Head and Neck Squamous Carcinoma Cell Lines , 1983, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[36]  C. H. Lee,et al.  Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes. , 2003, Oral oncology.

[37]  T. Ishida,et al.  Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway , 2001, Oncogene.

[38]  R. Jove,et al.  Activation of STAT3 by the c-Fes Protein-tyrosine Kinase* , 1998, The Journal of Biological Chemistry.

[39]  W. Leonard,et al.  Jaks and STATs: biological implications. , 1998, Annual review of immunology.

[40]  Monilola A. Olayioye,et al.  ErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases* , 1999, The Journal of Biological Chemistry.

[41]  J. Ihle.  STATs and MAPKs: obligate or opportunistic partners in signaling. , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[42]  J. Grandis,et al.  Differential function of STAT5 isoforms in head and neck cancer growth control , 2002, Oncogene.

[43]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[44]  R. Salgia,et al.  The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. , 1995, Experimental hematology.

[45]  J. Grandis,et al.  Downmodulation of TGF‐α protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells , 1998, Journal of cellular biochemistry.

[46]  J. Kuriyan,et al.  Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases. , 2002, Cancer research.

[47]  D. Schlaepfer,et al.  FRNK blocks v‐Src‐stimulated invasion and experimental metastases without effects on cell motility or growth , 2002, The EMBO journal.

[48]  Hua Yu,et al.  Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells , 2001, Oncogene.

[49]  T. Katada,et al.  Activation of Extracellular Signal-regulated Kinase by Ultraviolet Is Mediated through Src-dependent Epidermal Growth Factor Receptor Phosphorylation , 2002, The Journal of Biological Chemistry.

[50]  T. Wright,et al.  A unique palindromic element mediates gamma interferon induction of mig gene expression , 1994, Molecular and cellular biology.

[51]  S. Rane,et al.  JAKs, STATs and Src kinases in hematopoiesis , 2002, Oncogene.

[52]  S. Rane,et al.  IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled , 2000, Oncogene.

[53]  C. Snyderman,et al.  Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. , 1989, Cancer research.

[54]  P. Coffer,et al.  EGF receptor deletions define a region specifically mediating STAT transcription factor activation. , 1995, Biochemical and biophysical research communications.

[55]  M. Goldsmith,et al.  JAK/STAT signaling by cytokine receptors. , 1998, Current opinion in immunology.

[56]  N. Copeland,et al.  Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation , 1994, Molecular and cellular biology.

[57]  M. Matsuda,et al.  Real Time Fluorescence Imaging of Plcγ Translocation and Its Interaction with the Epidermal Growth Factor Receptor , 2001, The Journal of cell biology.

[58]  E. Reddy,et al.  Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation , 1998, Oncogene.

[59]  A. Bridges,et al.  A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. , 1994, Science.

[60]  J. Parsons,et al.  Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. , 1997, Current opinion in cell biology.

[61]  R. Jove,et al.  Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. , 1995, Science.

[62]  P. Slootweg,et al.  Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disorders. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[63]  W. Farrar,et al.  JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response. , 1999, Journal of immunology.